NORLEVO cpr 1.5 mg

7680628760017 CH-62876 G03AD01 09.02.1.
NORLEVO cpr 1.5 mg
NORLEVO cpr 1.5 mg
NORLEVO cpr 1.5 mg
1 / 3
google

Details

Product number
6287601
CPT
-
Packaging group
1
Unit
Tablette(n)
Composition
levonorgestrelum 1.5 mg, lactosum monohydricum 90.9 mg, maydis amylum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, pro compresso.

Articles (1)

Norlevo 1.5 mg, Tabletten
Tabletten
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
02/04/2025
Professional SmPC
Français
02/04/2025
Professional SmPC
Italien
02/04/2025
Patient information leaflet
Allemand
27/03/2025
Patient information leaflet
Français
27/03/2025
Patient information leaflet
Italien
27/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.5 MG Substance Wirkstoff (Principe actif)
(N/A)
90.9 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Perrigo Schweiz AG

8001 Zürich

Authorization information

Swissmedic authorization number
62876
Drug name
Norlevo 1.5 mg, Tabletten
Galenic form
TAB
ATC Code
G03AD01
Authorization status
Z
Dispensation category
B
First authorization
18/12/2013
Authorization expiration date
31/12/9999
IT number
09.02.1.
Domain
Human medicine
Field of application
Hormonales Kontrazeptivum zur Schwangerschaftsverhütung in Notfällen

Packaging details

Description (FR)
NORLEVO cpr 1.5 mg
Description (DE)
NORLEVO Tabl 1.5 mg
Market launch
18/12/2013
Narcotic (BTM)
No